SEC Charges Clinical Drug Trial Investigator with Insider Trading

The Securities and Exchange Commission today announced charges against Daniel V.T. Catenacci for insider trading in the securities of biotechnology company Five Prime Therapeutics, Inc. in advance of the company’s November 10, 2020 announcement that it…

Read the Full Press Release

Have a securities law question? Call New York Securities Lawyers at 212-509-6544.

Visit The Securities Law Home Page – news and tips from securities regulators and top securities attorneys